Plasma level of transforming growth factor β 1 in children with autism spectrum disorder

Egyptian Journal of Ear, Nose, Throat and Allied Sciences

Volumn 16, Issue 1, 2015, Pages 69-73

  El Gohary, Tarek Mohamed ^a   El Aziz, Nahal Abd ^a   Darweesh, Mohamed ^b   Sadaa, Ebtihal Shukery ^a  

^a TANTA UNIVERSITY   (Egypt)

^b TANTA UNIVERSITY   (Egypt)

Author keywords

Autism; CARS; DSM IV (TR); Neurodevelopmental disorders; TGF 1

Indexed keywords

EID: 84942077269     PISSN: 20900740     EISSN: 20903405     Source Type: Journal    
DOI: 10.1016/j.ejenta.2014.12.002     Document Type: Article

References (33)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC, [Text revision]. 4th ed.
2. Fombonne E. The epidemiology of autism: a review. Psychol Med 1999, 29:769-786.
3. Fombonne E. The prevalence of autism. JAMA 2003, 289:87-89.
4. Wiznitzer M. Autism and tuberous sclerosis. J Child Neurol 2004, 19:675-679.
5. Cohen D., Pichard N., Tordjman S., et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord 2005, 35:103-116.
6. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67-81. [Pub Med: 15546155].
7. 3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 2006, 173:126-134. [Pub Med: 16494951].
8. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R.L., et al. Decreased transforming growth factor beta l in autism: a potential link: between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 2008, 204:149-153. [Pub Med: 18762342].
9. Marra L.E., Zhang Z.X., Joe B., et al. IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J Immunol 2004, 172(2):1028-1035. [Pub Med: 14707076].
10. 8+ T cell response. J Immunol 2007, 178(9):5429-5433. [Pub Med: 17442923].
11. Ashwood P., Anthony A., Torrente F., Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004, 24(6):664-673. [Pub Med: 15622451].
12. Cohly H.H., Panja A. Immunological findings in autism. Int Rev Neurobiol 2005, 71:317-341. [Pub Med: 165123 5 6].
13. Jyonouchi H., Geng L., Ruby A., Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 2005, 51(2):77-85. [Pub Med: 15741748].
14. Okada K., Hashimoto K., Iwata Y., et al. Decreased serum levels of transforming growth factor-betal in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(1):187-190. [Pub Med: 17030376].
15. Snijders-Oomen, Nan Early assessment of autism. BC J Spec Educ 1979, 3(2):153-157.
16. Schopler E., Reichler R.J., Renner B.R. The childhood autism rating scale 1988, Western Psychological Services, Los Angeles, California.
17. APA. Diagnostic and statistical manual of mental disorders. Washington, DC; 1994.
18. Ashwood P., Wills S., Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 2006, 80(1):1-15.
19. Enstrom A.M., Van de Water J.A., Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs 2009, 10(5):463-473.
20. Paula Goines, Van de Water Judy The immune system's role in the biology of autism. Curr Opin Neurol 2011, April 1.
21. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 2007, 8(3):221-232.
22. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137-161.
23. Gomes F.C., Sousa Vde O., Romao L. Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 2005, 23(5):413-424.
24. Webb E., Lobo S., Hervas A., Scourfi eld J., Fraser W. The changing prevalence of autistic disorder in a Welsh health district. Dev Med Child Neurol 1997, 39:150-152.
25. Fombonne E., Zakarian R., Bennett A., Meng L., McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006, 118(1):139-150.
26. Lazoff T., Zhong L., Piperni T., Fombonne E. Prevalence rates of PDD among children in a Montreal school board. Can J Child Psychiatry 2010, 55(11):715-720.
27. Glasson E.J. The Western Australian register for autism spectrum disorders. J Paediatr Child Health 2002, 38(3):321-326.
28. Bhasin T.K., Schendel D. Sociodemographic risk factors for autism in a U.S. metropolitan area. J Autism Dev Disord 2006, 37(4):667-677.
29. Durkm M.S., Maenner M.J., Newschaffer C.J., et al. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 2008, 168(11):1268-1276.
30. El-Baz F., Ismael N.A., Nour Eldin S.M. Risk factors for autism: an Egyptian study. Egypt J Med Hum Genet 2011, 12(1):31-38.
31. Glasson E.J., Bower C., Petterson B., DeKlerk N., Chaney G., Hallmayer J.F. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004, 61(6):618-627.
32. Connolty A.M., Chez M., Streif E.M., et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 2006, 59(4):354-363.
33. Buehler M.R. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder. Med Hypotheses 2011, June, 76(6):863-870.